Bigora Sian 4
4 · Processa Pharmaceuticals, Inc. · Filed Apr 11, 2025
Insider Transaction Report
Form 4
Bigora Sian
Chief Development Officer
Transactions
- Tax Payment
Common Stock
2025-04-01$0.41/sh−3,311$1,364→ 33,626 total - Exercise/Conversion
Common Stock
2025-04-01+15,059→ 36,937 total
Holdings
- 6,668(indirect: By LLC)
Common Stock
Footnotes (1)
- [F1]Distribution of vested restricted shares.